Yan Ning
Impact in
- Oncology top 5%
- Colorectal Cancer Treatments and Studies
- Cancer Cells and Metastasis
- Chemokine receptors and signaling
- Cytokine Signaling Pathways and Interactions
- Cancer Immunotherapy and Biomarkers
- Cancer Research top 10%
- Cancer Genomics and Diagnostics
Papers in
- Oncology 47
- Colorectal Cancer Treatments and Studies 30
- Cancer Immunotherapy and Biomarkers 6
- Chemokine receptors and signaling 6
- Cancer Treatment and Pharmacology 5
-
- Lung Cancer Treatments and Mutations 9
- Co-authors
- Heinz‐Josef Lenz (39 shared papers)Wu Zhang (36 shared papers)Dongyun Yang (38 shared papers)Melissa J. LaBonte (8 shared papers)Alexandra Pohl (8 shared papers)Georg Lurje (7 shared papers)Thomas Winder (5 shared papers)Pierre Bohanes (10 shared papers)
- Journals
- Journal of Clinical Oncology (20 papers)Clinical Cancer Research (5 papers)Molecular Cancer Therapeutics (4 papers)European Journal of Cancer (3 papers)International Journal of Cancer (2 papers)
- Partner nations
- United StatesChinaItaly
In The Last Decade
Yan Ning
66 papers receiving 1.6k citations
Peers
Comparison fields: 5 of 99
- Oncology 816
- Cancer Research 272
- Immunology 265
- Hepatology 67
- Pathology and Forensic Medicine 151
Countries citing papers authored by Yan Ning
This map shows the geographic impact of Yan Ning's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yan Ning with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yan Ning more than expected).
Fields of papers citing papers by Yan Ning
This network shows the impact of papers produced by Yan Ning. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yan Ning. The network helps show where Yan Ning may publish in the future.
Co-authors
The 25 scholars most cited alongside Yan Ning, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 69 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2010 | 362 | |
| 2 | 2011 | 182 | |
| 3 | 2012 | 106 | |
| 4 | 2013 | 102 | |
| 5 | 2017 | 89 | |
| 6 | 2011 | 86 | |
| 7 | 2011 | 73 | |
| 8 | 2012 | 70 | |
| 9 | 2009 | 51 | |
| 10 | 2010 | 44 | |
| 11 | 2009 | 42 | |
| 12 | 2008 | 40 | |
| 13 | Molecular predictors of combination targeted therapies (cetuximab, bevacizumab) in irinotecan-refractory colorectal cancer (BOND-2 study). | 2010 | 32 |
| 14 | 2016 | 29 | |
| 15 | 2017 | 27 | |
| 16 | 2018 | 26 | |
| 17 | 2016 | 23 | |
| 18 | 2015 | 22 | |
| 19 | 2022 | 22 | |
| 20 | 2017 | 19 |
About Yan Ning
Yan Ning is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Cancer Research, Molecular Biology and Pathology and Forensic Medicine, having authored 69 papers that have together received 1.6k indexed citations. Recurring topics across this work include Colorectal Cancer Treatments and Studies (30 papers), Lung Cancer Treatments and Mutations (9 papers), Genetic factors in colorectal cancer (7 papers), Cancer Genomics and Diagnostics (6 papers), Cancer Immunotherapy and Biomarkers (6 papers), Chemokine receptors and signaling (6 papers), Cancer Treatment and Pharmacology (5 papers) and Reproductive System and Pregnancy (4 papers). The work is most often cited by research in Oncology (816 citations), Cancer Research (272 citations), Immunology (265 citations), Hepatology (67 citations) and Pathology and Forensic Medicine (151 citations). Yan Ning has collaborated with scholars based in United States, China and Italy. Frequent co-authors include Heinz‐Josef Lenz, Wu Zhang, Dongyun Yang, Melissa J. LaBonte, Alexandra Pohl, Georg Lurje, Thomas Winder, Pierre Bohanes, Philipp Manegold and Peter M. Wilson. Their work appears in journals such as Journal of Clinical Oncology, Clinical Cancer Research, Molecular Cancer Therapeutics, European Journal of Cancer and International Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.